These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 3307215)

  • 1. [Modification by cyclophosphamide of the effect of autovaccination in chronic pyelonephritis in an animal experiment].
    Straube E; Broschewitz U; Nimmich W; Naumann G; Hacker K
    Z Urol Nephrol; 1987 Jun; 80(6):353-63. PubMed ID: 3307215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preliminary results of the vaccine treatment of chronic pyelonephritis in animal experiments].
    Straube E; Broschewitz U; Schill H; Naumann G
    Z Urol Nephrol; 1984 Jul; 77(7):401-5. PubMed ID: 6385543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autovaccination in chronic pyelonephritis in the animal experiment--effect of cyclophosphamide on splenic and thymus lymphocytes].
    Straube E; Schütt W
    Z Urol Nephrol; 1987 Aug; 80(8):483-90. PubMed ID: 3318218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of immunization with Escherichia coli J5 on the course of experimental pyelonephritis in rats].
    Straube E; Naumann G; Broschewitz U
    Z Urol Nephrol; 1988 Apr; 81(4):247-55. PubMed ID: 3041706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Local autovaccine treatment of experimental urinary tract infections in the rat].
    Straube E; Broschewitz U
    Z Urol Nephrol; 1988 Jan; 81(1):1-12. PubMed ID: 3284238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of autovaccination on the course of urinary tract infection in animal experiment.
    Straube E; Broschewitz U; Naumann G; Schill H
    J Hyg Epidemiol Microbiol Immunol; 1985; 29(4):435-46. PubMed ID: 3910724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Incidence of antibody-coated bacteria in patients with chronic pyelonephritis].
    Falkenhagen U; Hacker K; Rehbock A; Handschuck I; Nimmich W
    Z Urol Nephrol; 1986 Nov; 79(11):609-18. PubMed ID: 3551385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of immunization with K1-antigen of Escherichia coli on the course of experimental urinary tract infection in the rat].
    Straube E; Nimmich W; Broschewitz U; Naumann G
    Z Urol Nephrol; 1986 Jun; 79(6):335-46. PubMed ID: 3529745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological enhancement in the pathogenesis of pyelonephritis.
    Miller TE; Burnham S; North JD
    Clin Exp Immunol; 1976 May; 24(2):336-45. PubMed ID: 776466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Production of O antigens and antibodies during urinary tract infections due to Escherichia coli (author's transl)].
    Fries D; Renault L; Mathieu D; Charpentier B; Guerin D; Jacques L
    Nouv Presse Med; 1979 Mar; 8(15):1239-43. PubMed ID: 375188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental Escherichia coli O6 pyelonephritis in rabbits. Effect on O6 antibody quantity and avidity of prior immunization with E. coli O2 bacteria.
    Ahlstedt S; Kaijser B
    Immunology; 1975 May; 28(5):841-6. PubMed ID: 1093966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of active immunisation on ascending pyelonephritis in the rat.
    Radford NJ; Chick S; Ling R; Coles GA; Asscher AW
    J Pathol; 1974 Mar; 112(3):169-75. PubMed ID: 4601025
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunoprotection of guinea pigs against experimental acute pyelonephritis after the administration of Escherichia coli purified fimbriae.
    Dima VF; Petrovici A; Dima SV; Petrovici M; Burghelea B
    Arch Roum Pathol Exp Microbiol; 1989; 48(3):215-25. PubMed ID: 2577515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunology of pyelonephritis in the primate model. II. Effect on immunosuppression.
    Roberts JA; Domingue GJ; Martin LN; Kim JC; Rangan SR
    Invest Urol; 1981 Nov; 19(3):148-53. PubMed ID: 6271703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The local immune response to Escherichia coli O and K antigen in experimental pyelonephritis.
    Smith JW; Kaijser B
    J Clin Invest; 1976 Aug; 58(2):276-81. PubMed ID: 783196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against experimental pyelonephritis by antibodies to pili.
    Silverblatt FJ; Weinstein R; Rene P
    Scand J Infect Dis Suppl; 1982; 33():79-82. PubMed ID: 6127805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escherichia coli K antigen.
    Kaijser B; Vahlne G
    Zentralbl Bakteriol Orig A; 1979 Apr; 243(2-3):271-88. PubMed ID: 377857
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic pyelonephritis: modulation of host defenses by cyclosporin A.
    Findon G; Miller TE
    J Lab Clin Med; 1989 Aug; 114(2):157-64. PubMed ID: 2666534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization against retrograde pyelonephritis. II. Prevention of retrograde Escherichia coli pyelonephritis with vaccines.
    Brooks SJ; Lyons JM; Braude AI
    Am J Pathol; 1974 Feb; 74(2):359-64. PubMed ID: 4590646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Excretion of antibody-coated bacteria in chronic pyelonephritis].
    Falkenhagen U; Handschuck I; Zingler G; Nimmich W; Naumann G
    Z Gesamte Hyg; 1989 Oct; 35(10):579-82. PubMed ID: 2694641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.